Francesca Barone, Chief Scientific Officer of Candel Therapeutics ($CADL), made one open market sale of common shares in the last year, totaling nearly $282,000. Her most recent sale occurred on March 18, 2025. Among 11,678 insiders with sales, her activity ranks 7,689th by value, well below the average of $8.6 million per person across about 6.4 transactions. Barone recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | A | Stock Option (Right to Buy) | 232000 | $0.00 | 232,000.0000 | 55,018,457 | 9999.99% | 0.42% |
| June 25, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | A | Common Stock | 4282 | $4.67 | 100,809.0000 | 46,933,088 | 4.44% | 0.01% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 32146 | $8.76 | 96,527.0000 | 46,933,088 | 24.98% | 0.07% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 30,822.0000 | 46,933,088 | 36.87% | 0.04% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | M | Common Stock | 18000 | $1.55 | 128,673.0000 | 46,933,088 | 16.26% | 0.04% |
| Feb. 12, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 46,933,088 | 9999.99% | 0.25% |
| Jan. 15, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 13534 | $7.23 | 110,673.0000 | 46,933,088 | 10.90% | 0.03% |
| Jan. 8, 2025 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 13673 | $8.22 | 124,207.0000 | 46,933,088 | 9.92% | 0.03% |
| Nov. 29, 2024 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 22081 | $4.56 | 137,880.0000 | 32,247,744 | 13.80% | 0.07% |
| July 17, 2024 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 14051 | $6.47 | 159,961.0000 | 31,186,817 | 8.07% | 0.05% |
| July 11, 2024 | Candel Therapeutics, Inc. | $CADL | Barone Francesca | Chief Scientific Officer | S | Common Stock | 12645 | $5.97 | 174,012.0000 | 31,186,817 | 6.77% | 0.04% |